about
Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin.Understanding the pharmacological properties of a metabolic PET tracer in prostate cancerHypoxic tumor microenvironments reduce collagen I fiber densityTemporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASHThe physiological environment in cancer vascularization, invasion and metastasis.Mapping Tumor Hypoxia In Vivo Using Pattern Recognition of Dynamic Contrast-enhanced MRI Data.Gaussian mixture model-based classification of dynamic contrast enhanced MRI data for identifying diverse tumor microenvironments: preliminary resultsVascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cellsNoninvasive MRI of endothelial cell response to human breast cancer cells.High-field small animal magnetic resonance oncology studies.Preclinical study of treatment response in HCT-116 cells and xenografts with (1) H-decoupled (31) P MRS.Choline phospholipid metabolism: a target in cancer cells?Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell lineVisualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment.Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment.Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism.Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.Choline phospholipid metabolism in cancer: consequences for molecular pharmaceutical interventions.Noninvasive multimodality imaging of the tumor microenvironment: registered dynamic magnetic resonance imaging and positron emission tomography studies of a preclinical tumor model of tumor hypoxia.Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levelsDelineation of Tumor Habitats based on Dynamic Contrast Enhanced MRIAutomation of pattern recognition analysis of dynamic contrast-enhanced MRI data to characterize intratumoral vascular heterogeneity.Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical ImagingRadiosynthesis of the tumor hypoxia marker [18F]TFMISO via O-[18F]trifluoroethylation reveals a striking difference between trifluoroethyl tosylate and iodide in regiochemical reactivity toward oxygen nucleophilesCorrigendum to "Noninvasive Multimodality Imaging of the Tumor Microenvironment: Registered Dynamic Magnetic Resonance Imaging and Positron Emission Tomography Studies of a Preclinical Tumor Model of Tumor Hypoxia" [Neoplasia 11 (2009) 247-259]Real-time measurements of cellular oxygen consumption, pH, and energy metabolism using nuclear magnetic resonance spectroscopy.Inhibition of prostate cancer proliferation by Deferiprone.Molecular and functional imaging of cancer: advances in MRI and MRS.Tumor stroma interaction is mediated by monocarboxylate metabolism.Investigation of native fluorescence spectral difference among prostate cancer cell lines with different risk levels
P50
Q30744878-172F7806-A8AF-4373-B09C-0B1E2AE22067Q33665586-88EB550D-9284-440E-A51A-C60605C20772Q34041303-91FD010C-4D51-48BD-ACB2-C0582B47AE8FQ34215586-CE19B0B2-39A5-489C-8C85-19AECEA805F8Q34452460-CC160D3B-3A7D-41EB-AEAA-4265BA8DDA10Q34552360-D9CA3AE9-BBA6-490E-A995-A77D73D04CE3Q34601310-B381F984-74EB-4805-AC01-C77C9A92412AQ34779401-37A188EB-0209-438B-8431-9097DAEA595EQ35046962-C78AFD98-3DA3-45B9-9CF3-EA009595D7DEQ35052184-68C656D1-ABEB-443A-82B7-2A5D4171D152Q35312455-40F1B0BA-FA0A-4843-BA3E-538F535D8114Q35445919-06ED105A-AB10-495D-B2CC-F66FF17217CCQ35549481-32764598-1A0E-46E0-B66E-111C8E0B8D84Q35728009-E32FED24-3350-4D9F-A7C1-65941B19B561Q35790990-893B739A-0781-46E9-BB55-89DAE8C74A10Q36108827-08813491-1D46-4D53-A485-1547EFE9E7B5Q36259662-F293BFA2-B6BC-4CCB-900B-BB212E2E0CD8Q36360129-A0262A64-439D-4AB5-B5F4-FFF3D2E323B0Q36607242-89B82C57-651B-4635-8094-2DE008D4C1DDQ37109541-4A3F31A8-60D4-447C-959B-AD24898CE90FQ37149502-D36A14AA-F37D-44DF-9539-A5A9F6952E58Q38603036-4E286190-2ED5-40A8-8622-A1500533C184Q38670392-E8F3F138-E17D-4332-AC7C-1655F4B8F830Q39135714-A52BC034-0404-4FF0-A873-5B77D3B7C268Q41281172-3CC3DF11-71E7-4061-ABE4-0BEE31866848Q42352784-143D3196-84D1-4CA6-A984-A57484B5D355Q43589396-C1435DC6-33A7-4C6D-8164-23C52F802E79Q48150564-A43138B5-3D7F-43B9-8845-05BA0506B35AQ51998408-BB6F648D-3983-488E-B922-960F27C6960EQ52918275-7EBD76A5-34B1-4C3F-B321-BD0341BF4A41Q57273323-A8905828-8892-4707-A768-EA3292DB318E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ellen Ackerstaff
@ast
Ellen Ackerstaff
@en
Ellen Ackerstaff
@es
Ellen Ackerstaff
@nl
Ellen Ackerstaff
@sl
type
label
Ellen Ackerstaff
@ast
Ellen Ackerstaff
@en
Ellen Ackerstaff
@es
Ellen Ackerstaff
@nl
Ellen Ackerstaff
@sl
prefLabel
Ellen Ackerstaff
@ast
Ellen Ackerstaff
@en
Ellen Ackerstaff
@es
Ellen Ackerstaff
@nl
Ellen Ackerstaff
@sl
P108
P106
P21
P31
P3835
ellen-ackerstaff
P496
0000-0003-4454-7481